|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||
|
|||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Human Cytochrome P450 2A6 (aa 1-494) |
| CYP2A3 Swiss Prot# | | P11509 |
| CYP2A3 Protein names | | Cytochrome P450 2A6 (EC 1.14.14.1) (CYPIIA6) (Coumarin 7-hydroxylase) (P450 IIA3) (CYP2A3) (P450(I)) |
| CYP2A3 Gene names | | CYP2A6 (CYP2A3) |
| Organism | | Human |
| CYP2A3 Entry name | | CP2A6_HUMAN |
| CYP2A3 Codon optimized cDNA(gene) Clone |
| CYP2A3 Cat # | | RPR0101 |
| Tag | | CYP2A3 contains A 6x histidine tag |
| CYP2A3 Formulation | | Liquid |
| CYP2A3 Storage | | Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| CYP2A3 Applications | | Applications: 1. Codon-optimized cDNA(gene) sequence designed for protein production in both E.coli and Mammalian cell. The cDNA(gene) has been cloned into E.coli expression vector with 6x Histidine tag.2. May be used as RNAi assistance to restore the loss-of-function. |
| Recombinant CYP2A3 Protein |
| CYP2A3 Cat # | | PR0101 |
| CYP2A3 Source | | recombinant |
| CYP2A3 Applications | | Western Blot, SDS-Page or may be used for other applications determined by user |
| CYP2A3 Purity | | >90%, as determined by SDS-PAGE under reducing conditions |
| CYP2A3 Activity | | N/A |
| Tag | | CYP2A3 Contains A 6x histidine tag |
| CYP2A3 Formulation | | Liquid |
| CYP2A3 Storage | | ;. Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| Place Order for Recombinant CYP2A3 Products | | For pricing and availability Click Here >>> |
| CYP2A3 family | | Cytochrome P450 family |
| CYP2A3 Subcellular locations | | Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein. |
| CYP2A3 FUNCTION According to UniProtKB Swiss Prot | | FUNCTION: Exhibits a high coumarin 7-hydroxylase activity. Can act in the hydroxylation of the anti-cancer drugs cyclophosphamide and ifosphamide. Competent in the metabolic activation of aflatoxin B1. Constitutes the major nicotine C-oxidase. Possesses low phenacetin O-deethylation activity. |
| CYP2A3 Sequence | | DDBJ | EMBL | GenBank |
| CYP2A3 3D structure | | ModBase |
| CYP2A3 interaction | | STRING |
| CYP2A3 Proteomic | | PRIDE |
| CYP2A3 Genome annotation | | Ensembl | GeneID | KEGG | UCSC |
| CYP2A3 Organism specific | | CTD | MGI |
| CYP2A3 Phylogenomics | | eggNOG | GeneTree | HOGENOM | HOVERGEN |
| | InParanoid | OrthoDB | PhylomeDB | OMA |
| CYP2A3 Gene expression | | Bgee | ArrayExpress | Genevestigator |
| CYP2A3 Family and domain | | InterPro | PROSITE | ProtoNet |
| FOR in vitro RESEARCH USE ONLY |